Business

Consumers have started the new year in a gloomy mood amid mounting concerns about job insecurity and whether the Reserve Bank will lift interest rates in the coming months.

Endeavour’s heavy discounting during the half-year helped lift sales at Dan Murphy’s and BWS, but it has come at the expense of profitability.

Paramount Skydance’s David Ellison will not take no for an answer. Rebuffed by Warner Bros for Netflix, Ellison is taking his cause to the courts.

Amanda Lacaze will step down as chief executive of Lynas Rare Earths after leading the miner from a “troubled startup” to the commodity’s biggest producer outside of China.

Apple has struck a deal to use Google's AI technology to power its new-look Siri and future artificial intelligence features on its iPhones.

Australians have kept spending at the fastest pace in two years while simultaneously becoming more pessimistic about their financial future than ever.

Once hooked up to the project’s wells and pipelines, the 70,000t rig will process gas from Scarborough before piping it to Woodside’s expanded Pluto LNG plant at Karratha for liquefication and export.

THE ECONOMIST: The race is on for Venezuelan spoils as Washington takes charge of the Orinoco reserves

An autistic Barbie is joining Mattel's line of fashion dolls that's intended to celebrate diversity and inclusion.

Shares in the company behind BCF, SuperCheap Auto and Rebel bombed on a profit miss during the retail trader’s most crucial shopping period. 

US President says he’s ‘inclined’ to keep ExxonMobil out of Venezuela after its top executive was sceptical about oil investment efforts in the country after the toppling of former President Nicolás Maduro.

THE ECONOMIST: Today, if ever, positive energy is in short supply. Pessimism has become both widespread and persistent.

Insurance giant boss says the company is on alert for potential increases in claims as a tropical cyclone affects north Queensland and the risks from fires persist in Victoria.

Prediction markets let people wager on anything from a basketball game to the outcome of a presidential election — and recently, the downfall of former Venezuelan President Nicolás Maduro.

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter.